1. Guidance for Industry: Expedited Programs for Serious Conditions – Drugs and Biologics;Food and Drug Administration,2014
2. Drugs@FDA;Food and Drug Administration,2015
3. Guidance for Industry – Priority Review of Drug Submissions;Health Canada,2012
4. Drug Products;Health Canada,2015
5. The measurement of observer agreement for categorical data;Landis;Biometrics,1977